Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_assertion type Assertion NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_head.
- NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_assertion description "[Overexpression of the receptor tyrosine kinase EPH receptor A2 (EphA2) is commonly observed in aggressive breast cancer and correlates with a poor prognosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_provenance.
- NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_assertion evidence source_evidence_literature NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_provenance.
- NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_assertion SIO_000772 18079969 NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_provenance.
- NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_assertion wasDerivedFrom befree-2016 NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_provenance.
- NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_assertion wasGeneratedBy ECO_0000203 NP645251.RAmURVcx2qX-W5m9FlOOZEub0Huc0ZOPRRFL4VOu9fhmo130_provenance.